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Abstract: Pectin is a polysaccharide with very good gel forming properties that traditionally has
found important applications in foods and pharmaceutical industries. Although less studied,
chemical modifications of pectin leading to a decrease in its hydrophilicity can be useful for the
development of novel drug carriers. To this aim, butylglyceryl pectins (P-OX4) were synthesized
via functionalization with n-butylglycidyl ether and subsequently formed into nanoparticles.
Chromatographic, spectroscopic, and thermal analytical methods were employed to characterize
the novel butylglyceryl pectins (P-OX4) obtained, prior to their formulation into nanoparticles via
nanoprecipitation. Nuclear magnetic resonance (NMR) and Fourier transform infrared (FT-IR)
spectroscopy confirmed a degree of modification in these materials in the range 10.4–13.6%,
and thermal stability studies indicated an increase in both the thermal decomposition onset and glass
transition temperature values (compared to those of the original pectin). An increase in the molecular
weight and a decrease in the viscosity of P-OX4, when compared to the starting material, were also
observed. The resulting nanoformulations were investigated in terms of particle morphology, size and
stability, and it was found that particles were roughly spherical, with their size below 300 nm,
and a negative zeta potential (−20 to −26 mV, indicating good stability). Having demonstrated the
ability to load Doxorubicin at the level of 10%, their potential in drug delivery applications warrants
further investigations.
Keywords: polysaccharides; alkylglycerols; N-butylglycidyl ether; pectin; nanoparticles
1. Introduction
In addition to their low cost, biocompatibility and biodegradability, the ease of chemical
modification with various conjugates make polysaccharides very promising materials for the design
of various carriers for drug delivery applications [1–3]. Among the common types of chemical
modifications applied to polysaccharides, the introduction of alkyl groups leads to the adjustment of
the hydrophilic lipophilic balance of the macromolecule, which is being used in turn for tuning its
interactions with living cells and ultimately for controlling its bioactivity. However, alkylation can
also change other important properties of polysaccharides such as their solubility and viscosity in
solution [4].
Several reagents can be used for the introduction of alkyl groups to polysaccharides; these
include epoxide derivatives such as alkylglycidyl ethers, which react with the free hydroxyl groups,
yielding hydrophobically tuned polysaccharides. This modification involves the opening of the
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epoxide ring in the presence of a strong base as a catalyst (such as potassium tert-butoxide, NaOH,
or tetrabutylammonium hydroxide) that can facilitate the formation of a strong nucleophile prior to
the addition of an alkylating or etherification agent [5].
Pectin, a component of the plant cell wall, is found in the middle lamella and is commonly extracted
from the primary cell wall of citrus peel or apple pomace [6,7]. It is a polysaccharide composed
primarily of linear polymers of d-galactopyranosyl uronic acid units joined via 1,4 α glycosidic bonds,
where the C6 carboxylic groups can be esterified to various degrees with methanol. There are also
literature reports indicating that this regular structure can be partially acetylated or interrupted with
l-rhamnopyranosyl units and with side chains containing other neutral sugars [8]. Pectin has good
solubility in water and, due to its excellent biodegradability and biocompatibility, it has been used in
targeting various proteins and drugs in various formulations such as hydrogels, films, microspheres,
and nanoparticles [9]. Pectin-based systems were mainly used for targeted colonic delivery [10–14],
but in some cases also to the brain [15,16]. Previous studies investigating alkylated pectin for drug
release applications have considered alkylation with alkyl bromides of varying chain length (butyl,
octanoyl, dodecyl, and cetyl) [17].
Rationalized by earlier studies that demonstrated the potential of alkylglycerols in promoting
increased drug transport into the brain when co-administered carotidally with model actives [18–20],
we focused on the preparation and investigation of alkyl glyceryl-modified polysaccharides as drug
carriers that could facilitate improved drug access to the brain [21,22]. We report here on the modification
of pectin with n-butylglycidyl ether and its formulation into nanoparticles via a nanoprecipitation method,
with a view to preliminary assess the potential of these materials for future drug delivery applications.
2. Materials and Methods
2.1. Materials
Pectin from citrus fruit (MW 17 kDa, 20–34% esterification, cat. no. P9311, batch no. 051M1378V),
butylglycidyl ether (BGE) (reagent grade 95%, cat. no. 377031), and NaOH were obtained from Sigma
Aldrich (Gillingham, UK). Dimethyl sulfoxide (DMSO), dichloromethane (DCM), trimethylamine,
and hydrochloric acid (HCL) was purchased from Fisher Scientific (Loughborough, UK). Doxorubicin
hydrochloride (cat. No. AD15377) was obtained from Carbosynth (Compton, UK).
2.2. Synthesis of Butylglyceryl-Modified Pectin
Pectin solution (0.40 g, 2.06 mmol) in deionized water (110 mL) was made alkaline (pH 12) using
NaOH (33% w/v) and stored in a freezer at −18 ◦C for 7 days. After thawing at room temperature, BGE
(5.60 mL, 39.14 mmol) was introduced dropwise into the solution under magnetic stirring; the mixture
was stirred further for 16 h at 45 ◦C, under N2 atmosphere. The solution was then neutralized using HCl
(10% v/v) and washed with DCM thrice to remove water-insoluble impurities. Additional purification
was done by dialysis (molecular weight cut-off, MWCO 12–14 kDa) against deionized water (10.0 L,
exchanged thrice per day) for 72 h, followed by the removal of volatile solvent traces using a Büchi
Rotavapor R-200 rotary evaporator (Büchi, Switzerland) and lyophilization (VirTis SP Scientific Sentry
2.0 freeze dryer, Genevac Ltd., Ipswich, UK) with flash-freezing in liquid N2. Butylglyceryl pectin
(P-OX4) that obtained as a white cotton-like material (yields 85–88%) was then characterized by FT-IR
and NMR spectroscopy, gel permeation chromatography (GPC) and thermal analysis.
2.3. Characterization of Butylglyceryl-Modified Pectin
The resulting lyophilized products were characterized by NMR spectroscopy using a JEOL Eclipse
400+ instrument (JEOL, Welwyn Garden City, UK; 400 MHz for 1H- and 100 MHz for 13C-NMR).
The samples were dissolved in D2O, with TMS (0.2% v/v) as reference. DS was calculated from the
1H- NMR spectra of P-OX4. FT-IR spectra were recorded using a Nexus Euro infrared spectrometer
(Thermo Fisher Scientific, Hemel Hempstead, UK) equipped with a diamond crystal ATR Smart
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Orbit accessory. Thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) were
performed using TG 209 F1 Libra (NETZSCH, Germany) and DSC 214 Polyma (NETZSCH, Selb,
Germany) instruments, respectively.
The viscosity of both pectin and P-OX4 was tested using a Gilmont Falling Ball Viscometer
(GV-2100, Gilmont Instruments Inc., Barrington, IL, USA). Samples were dissolved in deionized water
at 1% concentration. The viscometer constant was 0.3, the density of the glass ball 2.53 g/mL and the
density of the liquid 1.0 g/mL. The polymer solution was poured into the tube until nearly full (5 mL)
and the ball was carefully added and allowed to drop. The time taken for the ball to travel through the
sample solution was recorded.
Gel permeation chromatography (GPC) was performed using a Waters Alliance GPC 2000 system
(Waters Corporation, Milford, MA, USA) equipped with a PL-aquagel-OH column (8-µm particle size;
40 Å pore type) and refractive index detector, under controlled temperature conditions (30 ◦C). Either
a mixture of water/methanol (8:2, v/v) or 100% water (high-performance liquid chromatography, HPLC
grade) was used as the eluent at a flow rate of 0.5 mL/min. The molecular weight (MW) was estimated
based on the calibration conducted using pullulan standards (Showa Denko, New York, NY, USA) of
MWs 0.6 × 104, 1 × 104, 2.17 × 104, 4.88 × 104, 11.3 × 104, 21 × 104, 36.6 × 104, and 80.5 × 104 g/mol.
Statistical analysis was performed using the IBM SPSS Statistics Version 22 software (SPSS Inc., Chicago,
IL, USA, 2013). The results are expressed as mean ± standard deviation (SD); to determine statistical
significance, the p values were set at 0.05 unless stated otherwise.
2.4. Formulation of Nanoparticles from Butylglyceryl-Modified Pectin
Butylglyceryl-modified pectin (P-OX4) was dissolved in DMSO (2 mL) at different concentrations
(2, 5, 10, and 15 mg/mL); the solutions were filtered through a 0.2-µm nylon membrane Whatman
syringe filter and then introduced from a syringe to ultrapure water (8 mL) as the dispersion phase,
with vigorous magnetic stirring. The resulting nanoparticles were then either centrifuged (Beckman
Coulter, Fullerton, CA, USA, 70.1 Ti rotor; 40,000 rpm; 164,391 g; 30 min) or dialyzed (MWCO 12 kDa)
against deionized water (10 L; three exchanges per day) for 72 h. After purification, the products
were lyophilized. The nanoparticles were obtained (yield 42–81%) and redispersed (0.5 mg/mL) in
either ultrapure water or PBS (0.9% NaCl; pH 7.4) for characterization of the nanoformulation by using
dynamic light scattering (DLS), and electrophoretic mobility (EPM).
2.5. Physical Characterization of Butylglyceryl Pectin Nanoparticles
The hydrodynamic diameter of nanoparticles was measured by DLS using a Malvern
ZetasizerNano ZS instrument (Malvern Instruments Ltd., Worcestershire, UK) equipped with a 633-nm
He-Ne laser and controlled by Zetasizer v7.01 software (Malvern Instruments Ltd., Worcestershire, UK,
2011); the measurements were conducted at a scattering angle of 173◦ (Malvern Instruments, Malvern,
UK). The samples were analyzed in triplicate at 25 ◦C and the data was expressed as the Z-average
mean (Z-av.) and polydispersity index (PDI). Electrophoretic mobility (EPM) measurements were
conducted using the same instrument to determine the zeta potential (ZP) of nanoparticles; samples
were measured in folded capillary cells (DTS1070, Malvern) and data was processed according to
Smoluchowski’s model (Henry’s function f (ka) = 1.5).
Scanning electron microscopy (SEM) was employed to investigate the morphology of the
nanoparticles. The samples were prepared by redispersing the dried nanoparticles in ultrapure
water (10 mg/mL). A droplet was deposited onto a metallic stub and dried prior to coating with gold
alloy in an argon atmosphere by using a Q150RES sputter coater equipment (Quorum Technologies
Ltd., Ashford, UK).
2.6. Loading Capacity of Butylglyceryl Pectin Nanoparticles
The loading capacity of the nanoparticles for model actives such as Doxorubicin was investigated
following loading into nanoparticles via nanoprecipitation. Doxorubicin was purchased as
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hydrochloride salt and the removal of hydrochloride group was performed by treatment with
triethylamine as described: Triethylamine (0.1 mL) was introduced to an aqueous solution of
Doxorubicin HCl (10 mL; 50 mg/mL). The mixture was stirred for 1 h and washed with chloroform
thrice (approx. 150 mL). The combined organic layers were dried by stirring overnight with anhydrous
magnesium sulphate to remove water trace, and the remaining organic solvent was removed by a
Büchi Rotavapor R-200 rotary evaporator (Büchi, Switzerland), affording the free base of Doxorubicin
as red powder (yield 71–80%).
Doxorubicin solution (0.5 mL; 0.4 mg/mL) in DMSO was mixed with polymer solution during
nanoparticles preparation. The resulting nanoparticles were separated by ultracentrifugation
(40,000 rpm; 164,391 g; 30 min, 20 ◦C, Beckman, rotor 70.1 Ti); the pellets were lyophilized and
weighted; the supernatant was measured to determine the amount of unbound model actives (which
was used to calculate the amount of bound model actives) by UV/Vis (measuring at 486 nm for
Doxorubicin) and the results were plotted against the calibration curves. The drug loading was
calculated using Equation (1) [23,24]:
DL (%) =
weight o f drug
weight o f nanoparticles
× 100 (1)
3. Results and Discussion
A range of butylglyceryl-modified pectins (P-OX4) were synthesized by reacting commercially
available pectin (low degree of esterification) with BGE (Figure 1), via a nucleophilic substitution
reaction in a strong alkaline environment, following a method previously described in the literature for
chitosan. The strong alkaline environment was necessary to convert the hydroxyl groups of pectin into
alcoholates that react further with the oxirane ring via a nucleophilic substitution reaction [21,25]. Slow
freezing in alkaline prior to alkylation was previously reported to facilitate the chemical modification
of polysaccharides by enhancing their solubility as a result of breaking the intra and intermolecular
hydrogen bonds, disturbing the ordered molecular structure and decreasing crystallinity [26,27]. P-OX4
were obtained as white, low-density, cotton-like solids (yield 85–88%).
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Figure 1. Synthesis of butylglyceryl pectin (P-OX4). 
The alkylation of pectin was confirmed by FT-IR and NMR spectroscopic analyses. The broad 
and intense absorption band at 3331–3281 cm−1 (appearing in the spectra of both pectin and P-OX4, 
Figure 2) can be assigned to O–H stretching absorption due to the inter and intramolecular hydrogen 
bonding present in the galacturonic acid units [28,29]. The bands at 2930–2928 cm−1 can be attributed 
to C–H vibrations including CH, CH2, and CH3 stretching. The low-esterified pectin used in this study 
did not exhibit a distinct O–CH3 stretching band, normally appearing between 2950 and 2750 cm−1 
and attributed to the methyl esters of galacturonic acid, as reported in the literature [30,31], most 
likely masked by the large O–H stretching bands appearing in the region (3600–2500 cm−1). Two 
bands attributed to the carboxylate groups (COO−) were observed in both pectin and P-OX4: an 
asymmetric stretching band near 1609–1601 cm−1, and a weaker symmetric stretching band near 1409–
1402 cm−1 [30,32]. Comparing the FT-IR spectrum of P-OX4 with that of pectin, a higher intensity of 
the bands at 1027 and 1098 cm−1 (attributed to the formation of additional ether linkages C–O–C) can 
be observed for P-OX4. The band between 2400 and 2300 cm−1 (appearing in both samples, with 
variable intensity) was due to the atmospheric CO2 [33]. 
i r . .
The alkylation of pectin as confir ed by FT-IR and R spectroscopic analyses. The broad
and intense absorption band at 3331–3281 c −1 (appearing in the spectra of both pectin and P- X4,
Figure 2) can be assigned to – stretching absorption due to the inter and intra olecular hydrogen
bonding present in the galacturonic acid units [28,29]. The bands at 2930–2928 cm−1 can be attributed
to – vibrations including CH, CH2, and CH3 stretching. The low-esterified pectin used in this
study did not exhibit a distinct O–CH3 stretching band, normally appearing between 2950 and
2750 cm−1 and attributed to the methyl esters of galacturonic acid, as reported in the literature [30,31],
most likely masked by the large O–H stretching bands appearing in the region (3600–2500 cm−1).
Two bands attributed to the carboxylate groups (COO−) were observed in both pectin and P-OX4:
an asymmetric stretching band near 1609–1601 cm−1, and a weaker symmetric stretching band near
1409–1402 cm−1 [30,32]. Comparing the FT-IR spectrum of P-OX4 with that of pectin, a higher intensity
of the bands at 1027 and 1098 cm−1 (attributed to the formation of additional ether linkages C–O–C)
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can be observed for P-OX4. The band between 2400 and 2300 cm−1 (appearing in both samples,
with variable intensity) was due to the atmospheric CO2 [33].Polymers 2019, 11, x 5 of 12 
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The 1H- R spectru as also employed to calculate the degree of substitution (DS, defined
as the number of butylglyceryl c ains attached to 100 glucopyranose residues of pectin; e.g., 100%
indicates that one bstituted in each suga residue, with a maxi um value of 200%
when all available OH groups in each sugar residue of pectin ere ful y s stit (2):
DS (%) =
A × 100
3B
(2)
Polymers 2019, 11, 789 6 of 12
where
DS (%) Degree of substitution (number of butylglyceryl chains attached to 100 sugar residue of pectin)
A Integral value of the signal assigned to the alkyl chain-end CH3 group (δ 0.9 ppm)
B Integral value of the signal assigned to the anomeric C1 proton of the glucopyranose ring
(δ 5.0 ppm)
The formula used to calculate DS for P-OX4 was derived using the peak integrals attributed to
the end CH3 group alkyl chain (δ 0.9 ppm) and the anomeric proton at C1 (δ 5.0 ppm). The results
indicate degrees of substitution around 10.4–13.6%, a significant increase compared to previous
literature data reporting very low values obtained for alternative alkylation reactions (e.g., Morris et al.
alkylated pectin with p-carboxybenzyl bromide in an aqueous alkali medium, with very low DS values,
<0.1% [34]; Liang et al. reported alkylation with alkylglycerols of various alkyl chain lengths—hexyl,
dodecyl, or octadecyl—in the presence of TBAOH, with DS values that ranged from 0.6 to 4 [19]).
The reaction scheme (Figure 3) indicates that the substitution mainly takes place at C2, which is the
most reactive OH group [35–37].
GPC was performed to investigate the MW of P-OX4 and the results showed an increase of the
MW following modification (Table 1), which confirms the attachment of butylglyceryl-pendant chains
to the polysaccharide backbone of pectin (comparable to the results discussed by Devedec et al. [38]).
The polymer polydispersity index (PDI), as obtained by GPC and reported here, is based on the ratio
between MW and molecular number (Mn) and indicates the MW distribution of a polymer, with values
close to 1 indicating a narrow polymer distribution (i.e., more monodispersed). GPC chromatograms
of P-OX4 vs. pectin are exemplified in Figure 4.
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Table 1. Average molecular weight data for P-OX4 derivatives, as determined by gel permeation
chromatography (GPC) (n = 3, ±SD).
Compound Number AverageMolecular Weight (Mn)
Weight Average
Molecular Weight (Mw)
Polydispersity
Index (PDI)
Pectin 20,569 ± 276 25,037 ± 128 1.22 ± 0.10
P-OX4 27,044 ± 298 29,111 ± 252 1.13 ± 0.06
An example of the typical results obtained from thermal analysis is presented in Figure 5. Two
main steps corresponding to different mass-loss processes were identified in the TGA thermograms
of P-OX4 (% mass loss represented as a function of temperature). The first step was caused by the
evaporation of the humidity still present in the freeze-dried product (~11% water content), whereas
the second step (derivative thermogravimetry, DTG peak at ~245 ◦C, with a mass loss >53%) was
attributed to the thermal decomposition of the material, in accordance to literature [39].
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Table 2. Thermogravimetric analysis (TGA) results obtained for P-OX4 derivatives (n = 3, ± SD).
Material
Water Evaporation Decomposition Glass Transition,
Tg (◦C)DTG Peak (◦C) Mass Loss (%) DTG Peak (◦C) Mass Loss (%)
Pectin 56.2 ± 6.9 16.32 ± 8.1 215.4 ± 6.1 17.62 ± 7.4 22.4 ± 1.5
P-OX4 77.7 ± 7.4 10.72 ± 8.2 245.5 ± 8.9 53.99 ± 7.1 24.7 ± 1.6
The glass transition temperature (Tg) of pectin was also noted to shift to higher temperatures
following the substitution with BGE (Figure 5). This can perhaps be associated with an increase in the
bulkiness of the molecular structure following the insertion of the pendant chains, ultimately leading
to a decrease in mobility. Moisture has also been reported to act as a plasticizer, leading to an increase
in free volume and weakening the inter-chain interactions, which in turn lead to a decrease of the Tg of
amorphous solids such as the pectin [40–42]. The Tg values of pectin reported in the literature vary
considerably. Basu et al. investigated the Tg of pectin relative to its moisture content, and found that
the value decreased from 16.8 to −24.6 ◦C when the moisture content increased from 8 to 20% [40].
Mishra et al. studied the effect of graft polymerization of pectin with polyacrylamide, and discovered
that the Tg of pure pectin decreased after the grafting from 95 to 53 ◦C [43]. As Tg values depend on
the composition of each particular sample, the differences observed could potentially be explained
variations in the batch composition, MW and water content [44,45].
A falling-ball viscometer was used to assess the alkylation effect on the viscosity of pectins, which
was calculated using Equation (3):
η = K(ρt − ρ)·t (3)
where
η Viscosity (in centipoise, cp)
ρt Density of ball (g/mL)
ρ Density of liquid (g/mL)
t Time of the ball descent in the liquid (mins)
K Viscometer constant (depending on ball size)
The results show that P-OX4 has a reduced viscosity compared to that of pectin (Table 3), possibly
due to reduced inter and intramolecular hydrogen bonding as a result of the introduction of the bulky
alkyl glyceryl chains [46].
Table 3. Results of viscosity measurements (n = 3; ±SD).
Samples Time of Descent t (min) Viscosity η (cp)
Pectin 0.80 ± 0.1 0.37 ± 0.1
P-OX4 0.61 ± 0.1 0.28 ± 0.1
P-OX4 was further investigated for its ability to form nanoparticulates that might be suitable as
drug vehicles, and we found that nanoprecipitation (previously applied for dextrans [47,48]) is also
one of the most appropriate methods applicable to hydrophobized pectins. P-OX4 dissolved in DMSO
is simply subjected to dialysis under controlled conditions, when the material easily self-assemble
into micro and nanoparticulates having a close-to-spherical morphology (Figure 6). For comparison
purposes, we attempted to prepare pectin nanoparticles using the same technique employed for
P-OX4 (i.e., nanoprecipitation), but we were not successful as the solubility of normal pectin at similar
concentrations is very different from P-OX4.
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The process has been repeated at different polymer concentrations, and the results indicated that
P-OX4 (5 mg/mL) exhibited the smallest size (though the difference was not significant; ANOVA,
p < 0.05) and had good polydispersity index (indicative of uniform distribution). Particles around 250
nm showing good polydispersity (PDI < 0.5) and negative zeta potential (−20 to −26 mV, indicative of
stable formulations [49]) can be prepared without difficulty (Tabl 4). It has been observed that an
increase in concentration above 10 mg/mL leads to an in rease in size.
Table 4. Characteristics of nanoparticles prepared from P-OX4 by nanoprecipitation (n = 3; ±SD).
Polymer Concentration (mg/mL) Diameter (nm) Polydispersity Index Zeta Potential (mV)
P-OX4
2 253.9 ± 11.1 0.18 ± 0.09 −20.4 ± 2.1
5 1 1 3 9 0.10 ± 0.08 −22.7 ± 3.0
10 252.9 12.4 0.20 ± 0.10 −24.2 ± 2.8
15 279.9 ± 18.9 0.21 ± 0.12 −26.2 ± 3.3
In a preliminary study, a formulation of nanoparticles that exhibited the smallest size (conc.
of 5 mg/mL P-OX4) was selected, and doxorubicin was employed as a model active in order to
investigate the drug loading ability of these nanoparticles. The chemotherapeutic agent was loaded
during th nanoprecipitation stage, and the degree of loading was determined by UV–Vis to be
10.4 ± 1.8% (n = 3; ±SD), similar to previous r ports on doxorubicin loaded into pectin nanoparticles
via microemulsification with 18% drug loading) [50]. The size of the l aded nanoparticles was
investigated using DLS, and the results indicated a significant increase in size (ANOVA, p < 0.05),
to about 280.1 ± 4.2 nm, with −19.8 ± 2.1 mV zet potenti l, and h ving 0.10 ± 0.05 polydispersity
index (n = 3; ±SD).
4. Conclusions
Butylglyceryl-modified pectins (P-OX4) with increased amphiphilicity can be easily prepared via
a typical nucleophilic substitution reaction with n-butylglycidyl ether; the successful modification,
with degree of substitution of around 10.4–13.6%, was confirmed by FT-IR and NMR sp ctroscopy as
well as by GPC. Results of the thermal stability stu ies (TGA, DSC) indicated that the modification
led to an increase in both the glass transition (Tg) and decomposit on onset temperature values
compared to th se of pectin, most lik ly as a result of the macromolecular motion-limiting effect f the
newly introduced pendant chains. Our results demonstrate that these novel materials can be asily
formulated—by nanoprecipitation, via self-assembly—i o st ble formulations containing particulates
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below 300 nm size, with good polydispersity index and a drug loading degree of 10.4 ± 1.8% (when
loaded with Doxorubicin). We believe these characteristics warrant further investigations into the
potential of butylglyceryl pectins (P-OX4) in drug delivery applications.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4360/11/5/789/s1,
Figure S1: 1H-NMR spectra of n-butylglycidyl ether (BGE) in deuterated methanol (CD3OD) (10 mg/mL).
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